Caro, H.N. et al., “Isolation and Partial Characterisation of Insulin-Mimetic Inositol Phosphoglycans from Human Liver,” 61(2) Biochemical nd Molecular Medicine 214-228 (Aug. 1997). |
Farese, R. et al., “Insulin-Induced Activation of Glycerol-3-Phosphate Acyltransferase by a chiro-Inositol-Containing Insulin Mediator is Defective in Adipocytes of Insulin-Resistant, Type II Diabetic, Goto-Kakizaki Rats,” 91 Pro. Natl. Acad. Sci. 11040-11044 (Nov. 1994). |
Fonteles, M. et al., “Infusion of pH 2.0 D-chiro-Inositol Glycan Insulin Putative Mediator Normalizes Plasma Glucose in Streptozotocin Diabetic Rats at a Dose Equivalent to Insulin Without Inducing Hypoglycaemia,” 39 Diabetologica 731-734 (1996). No Month Available. |
Huang, L. et al., “Chiroinositol Deficiency and Insulin Resistance. III. Acute Glycogenic and Hypoglycemic Effects of Two Inositol Phosphoglycan Insulin Mediators in Normal and Streptozotocin-Diabetic Rats in Vivo *,” 132(2) Endocrinology 652-657 (1993). No Month Available. |
Kennington, A. et al., “Low Urinary chiro-Inositol Excretion in Non-Insulin-Dependent Diabetes Mellitus,” 323(6) The New England Journal of Medicine 373-378 (1990). No Month Available. |
Kunjara S. et al., “Tissue Specific Release of Inositol Phophoglycans,” in Biopolymers and Bioproducts: Structure, Function, and Applications, J. Svast et al. (ed), Dokya Publications, 301-306 (1995). No Month Available. |
Lazar, D. et al., “Stimulation of Glycogen Synthesis by Insulin in Human Erythroleukemia Cells Requires the Synthesis of Glycosy-Phophatidylinositol,” 91 Proc. Natl. Acad. Sci. 9665-9669 (Oct. 1994). |
Macaulay, S. and Larkins, R., “Impaired Insulin Action in Adipocytes of New Zealand Obese Mice: A Role for Postbinding Defects in Pyruvate Dehydrogenase and Insulin Mediator Activity,” 37(10) Metabolism 958-965 (Oct. 1988). |
Macaulay, S. et al., “Correlation of Insulin Receptor Level with Both Insulin Action and Breakdown of a Potential Insulin Mediator Precursor; Studies in CHO Cell-Lines Transfected with Insulin Receptor cDNA,” 1134 Biochimica et Biophysical Acta 53-60 (1992). No Month Available. |
Malchoff, C. et al., “A Putative Mediator of Insulin Action Which Inhibits Adenylate Cyclase and Adenosine 3′5′-Monophosate-Dependent Protein Kinase: Partial Purification from Rat Liver: Site and Kinetic Mechanism of Action,” 120(4) Endocrinology 1327-1337 (Apr. 1987). |
Monuki, E. et al. “Cell-Specific Action and Mutable Structure of a Transcription Factor Effector Domain,” 90 Proc. Natl. Acad. Sci. 9978-9982 (Nov. 1993). |
Nestler, J. et al, “Insulin Mediators are the Signal Transduction System Responsible for Insulin's Actions on Human Placental Steroidogenesis,” 129(6) Endocrinology 2951-2956 (1991). No Month Available. |
Ortmeyer, H. et al., “Chiroinositol Deficiency and Insulin Resistance. I. Urinary Excretion Rate of Chiroinositol Is Directly Associated with Insulin Resistance in Spontaneously Diabetic Rhesus Monkeys,” 132(2) Endocrinology 640-645 (1993). No Month Available. |
Ortmeyer, H. et al., “Chiroinositol Deficiency and Insulin Resistance. II. Acute Effects of D-Chiroinositol Administration in Streptozotocin-Diabetic Rats, Normal Rats Given a Glucose Load, and Spontaneously Insulin-Resistant Rhesus Monkeys,” 132(2) Endocrinology 646-651 (1993). No Month Available. |
Ostlund, R. et al., “D-chiro-Inositol metabolism in diabetes mellitus,” 90 Proc. Natl. Acad. Sci. USA 9988-9992 (Nov. 1993). |
Rademacher, T. et al., “Inositolphosphoglycan Second Messengers,” 27 Brazilian J. Med. Biol. Res. 327-341 (1994). No Month Available. |
Represa, J. et al., “Glycosyl-Phosphatidylinositol/Inositol Phosphoglycan: A Signaling System for the Low-Affinity Nerve Growth Factor Receptor,” 88 Proc. Natl. Acad. Sci. 8016-8019 (Sep. 1991). |
Romero, G, et al., “Anti-Inositolglycan Antibodies Selectively Block Some of the Actions of Insulin in Intact BC3H1 Cells,” 87 Proc. Natl. Acad. Sci. 1476-1480 (Feb. 1990). |
Suzuki, S. et al., “Urinary chiro-inositol Excretion is an Index Marker of Insulin Sensitivity in Japanese Type II Diabetes,” 17(12) Diabetes Care 1465-1468 (Dec. 1994). |
Villalba, M. et al., “Hydrolysis of Glycosyl-Phophatidylinositol in response to Insulin is Reduced in Cells Bearing Kinase-Deficient Insulin Receptors,” 2 Growth Factors 91-97 (1990). No Month Available. |
Villalba, M. et al., “Inhibition of cyclic AMP-dependent protein kinase by the polar head group of an insulin-senstive glycophospholipid,” 968 Biochimica et Biophysica Acta 69-76 (1988). No Month Available. |